Multidimensional Healthcare Access Barriers to Prostate‐Specific Antigen Testing: A Nation‐Wide Panel Study in the United States From 2006 to 2020
Physician recommendation was the strongest predictor of receipt of PSA testing, regardless of sociodemographic grouping. Future studies should consider access barriers jointly and across sociodemographic strata.
Authors
- Kevin H. Kensler (ORCID: https://orcid.org/0000-0001-7515-7270)
- Evan Kovac (ORCID: https://orcid.org/0000-0002-9153-0474)
- Charlotte Roscoe (ORCID: https://orcid.org/0000-0002-9169-6458)
- Timothy Richard Rebbeck (ORCID: https://orcid.org/0000-0002-4799-1900)
- Hari S. Iyer (ORCID: https://orcid.org/0000-0002-7596-9049)
- Isla P. Garraway (ORCID: https://orcid.org/0000-0002-1129-4636)
- Chidinma Opara
- Mingchao He
Institutions
- Rutgers, The State University of New Jersey (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- Cornell University (US)
- Dana-Farber Cancer Institute (US)
- VA Greater Los Angeles Healthcare System (US)
- Rutgers Cancer Institute (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/cam4.70358
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- U.S. Department of Defense
- Prostate Cancer Foundation
- Jean Perkins Foundation
- National Institutes of Health